Widely used:Recently Viewed
Clear All₹26.13
₹-1.37
(-4.98%)
As on 19-Jun-2025 10:37IST
Today’s Range
52 Week Range
Liquidity
Market cap
₹27 Cr
Revenue (TTM)
₹14 Cr
Net Profit (TTM)
₹-2 Cr
ROE
-5.1 %
ROCE
-2.7 %
P/E Ratio
138.6
P/B Ratio
1
Industry P/E
173.95
EV/EBITDA
46.4
Div. Yield
0 %
Debt to Equity
0.5
Book Value
₹22.6
EPS
₹-2.1
Face value
10
Shares outstanding
10,500,000
CFO
₹-19.89 Cr
EBITDA
₹27.59 Cr
Net Profit
₹5.76 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Global Longlife
| -15.7 | 18.8 | 13.6 | -24.3 | -27.6 | -- | -- |
|
BSE Healthcare
| -5.0 | 1.1 | 6.0 | 15.6 | 26.9 | 21.6 | 10.3 |
|
BSE Small Cap
| -3.9 | 3.2 | 17.0 | 1.9 | 29.7 | 34.2 | 17.0 |
|
Company
|
2024
|
2023
|
|---|---|---|
|
Global Longlife
| -26.2 | -23.7 |
|
BSE Small Cap
| 29.0 | 47.5 |
|
BSE Healthcare
| 43.1 | 37.0 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Global Longlife
|
26.1 | 27.4 | 13.5 | -2.2 | -- | -5.1 | 138.6 | 1.0 |
| 58.0 | 59.7 | 22.0 | 2.1 | 9.2 | -- | 29.5 | -- | |
| 409.5 | 12,997.3 | 1,332.2 | 95.1 | -- | 9.7 | 155.7 | 7.0 | |
| 17.6 | 7.6 | 4.8 | 0.6 | -- | 6.7 | 18.2 | 0.8 | |
| 1,509.9 | 9,900.5 | 1,261.6 | 193.5 | 18.7 | 15.3 | 51.5 | 7.3 | |
| 71.1 | 147.6 | 49.6 | 0.7 | 0.9 | 1.2 | 199.2 | 2.5 | |
| 161.4 | 52.9 | 16.6 | 7.7 | 7.2 | 19.3 | 6.8 | 1.4 | |
| 22.4 | 33.2 | 0.0 | -0.3 | -- | -2.1 | -- | 2.7 | |
| 53.5 | 22.8 | 31.2 | -0.2 | 2.5 | -14.8 | -- | 16.0 | |
| 943.8 | 9,711.1 | 681.4 | 143.8 | 29.7 | 18.9 | 67.9 | 12.2 |
No Review & Analysis are available.
Hospital activities
Incorporated
2012
Chairman
--
Managing Director
Dhruv Sureshkumar Jani
Headquarters
Ahmedabad, Gujarat
Website
Looking for more details about Global Longlife Hospital and Research Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The total asset value of Global Longlife Hospital and Research Ltd stood at ₹ 42 Cr as on 31-Mar-24
The share price of Global Longlife Hospital and Research Ltd is ₹26.13 (BSE) as of 19-Jun-2025 10:37 IST. Global Longlife Hospital and Research Ltd has given a return of -27.63% in the last 3 years.
Global Longlife Hospital and Research Ltd has a market capitalisation of ₹ 27 Cr as on 19-Jun-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Global Longlife Hospital and Research Ltd is 1.02 times as on 19-Jun-2025, a 61% discount to its peers’ median range of 2.62 times.
The P/E ratio of Global Longlife Hospital and Research Ltd is 138.57 times as on 19-Jun-2025, a 20% discount to its peers’ median range of 173.95 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Global Longlife Hospital and Research Ltd and enter the required number of quantities and click on buy to purchase the shares of Global Longlife Hospital and Research Ltd.
Hospital activities
The promoters of Global Longlife Hospital and Research Ltd are DHRUV SURESHKUMAR JANI and SUCHETA DHRUVKUMAR JANI. They collectively own 54.27 per cent of the total equity. The chairman of the company is
There is no promoter pledging in Global Longlife Hospital and Research Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
149
|
|
|
62
|
|
|
54
|
|
|
34
|
|
|
21
|
|
|
7
|
|
|
11,858
|
|
|
9,993
|
|
|
9,763
|
| Global Longlife Hospital and Research Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
-5.11
|
|
Operating margin(%)
|
-11.35
|
|
Net Margin(%)
|
-16.12
|
|
Dividend yield(%)
|
0
|
No, TTM profit after tax of Global Longlife Hospital and Research Ltd was ₹-2 Cr.
